The FDA has approved Spravato nasal spray to treat major depressive disorder

Spravato nasal spray, also known as esketamine, can now be used to treat depression in adults with treatment-resistant depression.

     

 

 

from USATODAY - News Top Stories https://ift.tt/2VIBHbh